FdaApplication
NDA 212121
Identifiers
- fda_app_no: NDA212121
Properties
| Property | Value |
|---|---|
| applicant_name | CMP DEVELOPMENT LLC |
| application_type | NDA |
| approval_date | 2019-09-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION;INTRAVENOUS |
1 product